|
HY-P1454A-10mg
|
MedChemexpress LLC
|
Fz7-21 (TFA)
|
|
Cancer-programmed cell death
|
|
|
HY-P1454A-5mg
|
MedChemexpress LLC
|
Fz7-21 (TFA)
|
|
Cancer-programmed cell death
|
|
|
HY-P1454A-50mg
|
MedChemexpress LLC
|
Fz7-21 (TFA)
|
|
Cancer-programmed cell death
|
|
|
HY-P1454-1mg
|
MedChemexpress LLC
|
Fz7-21 [CAS 2247635-23-8]
|
|
Cancer-programmed cell death
|
|
|
HY-P1454-10mg
|
MedChemexpress LLC
|
Fz7-21 [CAS 2247635-23-8]
|
|
Cancer-programmed cell death
|
|
|
HY-P1454-5mg
|
MedChemexpress LLC
|
Fz7-21 [CAS 2247635-23-8]
|
|
Cancer-programmed cell death
|
|
|
HY-P1592A-1mg
|
MedChemexpress LLC
|
G3-C12 (TFA)
|
|
Cancer-programmed cell death
|
|
|
HY-P1592A-10mg
|
MedChemexpress LLC
|
G3-C12 (TFA)
|
|
Cancer-programmed cell death
|
|
|
HY-P1592A-5mg
|
MedChemexpress LLC
|
G3-C12 (TFA)
|
|
Cancer-programmed cell death
|
|
|
HY-P1592-1mg
|
MedChemexpress LLC
|
G3-C12 [CAS 848301-94-0]
|
|
Cancer-programmed cell death
|
|
|
HY-P1592-10mg
|
MedChemexpress LLC
|
G3-C12 [CAS 848301-94-0]
|
|
Cancer-programmed cell death
|
|
|
HY-P1592-5mg
|
MedChemexpress LLC
|
G3-C12 [CAS 848301-94-0]
|
|
Cancer-programmed cell death
|
|
|
HY-P0323A-1mg
|
MedChemexpress LLC
|
GP(33-41) (TFA)
|
|
COVID-19-anti-virus
|
|
|
HY-P0323A-10mg
|
MedChemexpress LLC
|
GP(33-41) (TFA)
|
|
COVID-19-anti-virus
|
|
|
HY-P0323A-5mg
|
MedChemexpress LLC
|
GP(33-41) (TFA)
|
|
COVID-19-anti-virus
|
|
|
HY-P99263-1mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P99263-10mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P99263-5mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-N2600-1mg
|
MedChemexpress LLC
|
Kuwanon H [CAS 76472-87-2]
|
|
Cancer-programmed cell death
|
|
|
HY-19313-10mg
|
MedChemexpress LLC
|
LLY-507 [CAS 1793053-37-8]
|
|
Cancer-programmed cell death
|
|
|
HY-19313-25mg
|
MedChemexpress LLC
|
LLY-507 [CAS 1793053-37-8]
|
|
Cancer-programmed cell death
|
|
|
HY-19313-5mg
|
MedChemexpress LLC
|
LLY-507 [CAS 1793053-37-8]
|
|
Cancer-programmed cell death
|
|
|
HY-19313-50mg
|
MedChemexpress LLC
|
LLY-507 [CAS 1793053-37-8]
|
|
Cancer-programmed cell death
|
|
|
HY-19313-1mL
|
MedChemexpress LLC
|
LLY-507 [CAS 1793053-37-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P1205A-10mg
|
MedChemexpress LLC
|
MCH(human, mouse, rat) (TFA)
|
|
Neuroscience-Neuromodulation
|
|
